M7G (3'-OMe-5') pppA (2'-OMe)
M7G (3'-OMe-5') pppA (2'-OMe) is a modified cap analog. M7G (3'-OMe-5') pppA (2'-OMe) enhances the stability and translation efficiency of mRNA by maintaining the correct orientation of the mRNA cap, promoting cap-dependent translation initiation, and mimicking the Cap-1 structure to reduce immunogenicity. M7G (3'-OMe-5') pppA (2'-OMe) can be used in molecular biology research, vaccine development, and gene therapy applications.
For research use only. We do not sell to patients.
- CAS No.: 3047739-39-6
- Formula: C23H33N10O17P3
- Molecular Weight:814.49
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Description
In Vitro
M7G (3'-OMe-5') pppA (2'-OMe) (2 h) enables the synthesis of mRNA with predominantly forward cap structure, extremely high relative translation efficiency, strong stability and low immunogenicity during in vitro transcription reactions with phage RNA polymerase[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3047739-39-6
-
Molecular Weight 814.49
-
Formula C23H33N10O17P3
-
SMILES
NC1=NC=NC2=C1N=CN2[C@H]3[C@H](OC)[C@H](O)[C@@H](COP(OP(OP(OC[C@H]4O[C@@H](N(C=[N+]5C)C6=C5C(NC(N)=N6)=O)[C@H](O)[C@@H]4OC)([O-])=O)(O)=O)(O)=O)O3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (276 KB)
-
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- M7G (3'-OMe-5') pppA (2'-OMe)
- 3047739-39-6
- DNA/RNA Synthesis
- mRNA
- intracellular pattern recognition receptors
- bacteriophage RNA polymerases
- gene therapy
- cap-dependent translation
- eukaryotic Cap-1 structure
- in vitro mRNA transcription
- vaccine development
- m7G moiety
- translation initiation factor
- Inhibitor
- inhibitor
- inhibit